Citations

Mayo Clinic

Showing 10 of 108602 citations.

Microfluidic ‘Brain-on Chip’ Systems to Supplement Neurological Practice: Development, Applications and Considerations
Jarrah, Ryan , Nathani, Karim Rizwan , Bhandarkar, Shaan , Ezeudu, Chibuze S., Nguyen, Ryan T. , Amare, Abrham, Aljameey, Usama A., Jarrah, Sabrina I., Bhandarkar, Archis R. , Fiani, Brian , Nathani, Karim Rizwan , Nguyen, Ryan T

Regenerative Medicine | April 26, 2023 | Volume: 18 | Issue: 5 | Pages: 413-423

10.2217/rme-2022-0212 | PMID 37125510 Get It

Transcatheter Aortic Valve Replacement Prognostication with Augmented Mean Arterial Pressure
Agasthi, Pradyumna , Seri, Amith Reddy , Barry, Timothy , Shanbhag, Anusha , Wang, Yuxiang , Eleid, Mackram F. , Fortuin, David, Sweeney, John P., Pollak, Peter , Sabbagh, Abdallah El , Lester, Steven J., Freeman, William K., Naqvi, Tasneem Z. , Holmes, David R. , Appleton, Christopher P., Arsanjani, Reza , Seri, Amith R, Barry, Timothy , Arsanjani, Reza , Chao, Chieh‐Ju

Journal of Cardiovascular Development and Disease | April 26, 2023 | Volume: 10 | Issue: 5 | Pages: 192

10.3390/jcdd10050192 | PMID 37233159 Get It

Background: Post-transcatheter aortic valve replacement (TAVR) patient outcome is an important research topic. To accurately assess post-TAVR mortality, we examined a family of new echo parameters (augmented systolic blood pressure (AugSBP) and arterial mean pressure (AugMAP)) derived from blood pressure and aortic valve gradients. Methods: Patients in the Mayo Clinic National Cardiovascular Diseases Registry-TAVR database who underwent TAVR between 1 January 2012 and 30 June 2017 were identified to retrieve baseline clinical, echocardiographic and mortality data. AugSBP, AugMAP and valvulo-arterial impedance (Zva) (Zva) were evaluated using Cox regression. Receiver operating characteristic curve analysis and the c-index were used to assess the model performance against the Society of Thoracic Surgeons (STS) risk score. Results: The final cohort contained 974 patients with a mean age of 81.4 ± 8.3 years old, and 56.6% were male. The mean STS risk score was 8.2 ± 5.2. The median follow-up duration was 354 days, and the one-year all-cause mortality rate was 14.2%. Both univariate and multivariate Cox regression showed that AugSBP and AugMAP parameters were independent predictors for intermediate-term post-TAVR mortality (all p < 0.0001). AugMAP1 < 102.5 mmHg was associated with a 3-fold-increased risk of all-cause mortality 1-year post-TAVR (hazard ratio 3.0, 95%confidence interval 2.0–4.5, p < 0.0001). A univariate model of AugMAP1 surpassed the STS score model in predicting intermediate-term post-TAVR mortality (area under the curve: 0.700 vs. 0.587, p = 0.005; c-index: 0.681 vs. 0.585, p = 0.001). Conclusions: Augmented mean arterial pressure provides clinicians with a simple but effective approach to quickly identify patients at risk and potentially improve post-TAVR prognosis.
Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG‐ACRIN analysis
Foran, James M. , Sun, Zhuoxin , Lai, Catherine , Fernández, Hugo F. , Cripe, Larry D., Racevskis, Janis, Luger, Selina M. , Paietta, Elisabeth , Zhang, Yanming , Bennett, John M. , Levine, Ross L. , Rowe, Jacob M. , Litzow, Mark R. , Tallman, Martin S. , Lai, Catherine , Ketterling, Rhett P. , Lazarus, Hillard M.

Cancer | April 26, 2023 | Volume: 129 | Issue: 16 | Pages: 2479-2490

10.1002/cncr.34807 | PMID 37185873 Get It

AbstractBackgroundObesity (body mass index [BMI] ≥30 kg/m2) is an important epidemiological risk factor for developing acute myeloid leukemia (AML). Therefore, the authors studied the association of obesity with clinical and genetic phenotype and its impact on outcome in adults with AML.MethodsThe authors analyzed BMI in 1088 adults who were receiving intensive remission induction and consolidation therapy in two prospective, randomized therapeutic clinical trials of the Eastern Cooperative Oncology Group‐American College of Radiology Imaging Network: E1900 (ClinicalTrials.gov identifier NCT00049517; patients younger than 60 years) and E3999 (ClinicalTrials.gov identifier NCT00046930; patients aged 60 years or older).ResultsObesity was prevalent at diagnosis (33%) and, compared with nonobesity, was associated with intermediate‐risk cytogenetics group (p = .008), poorer performance status (p = .01), and a trend toward older age (p = .06). Obesity was not associated with somatic mutations among a selected 18‐gene panel that was tested in a subset of younger patients. Obesity was not associated with clinical outcome (including complete remission, early death, or overall survival), and the authors did not identify any patient subgroup that had inferior outcomes based on BMI. Obese patients were significantly more likely to receive <90% of the intended daunorubicin dose despite protocol specification, particularly in the E1900 high‐dose (90 mg/m2) daunorubicin arm (p = .002); however, this did not correlate with inferior overall survival on multivariate analysis (hazard ratio, 1.39; 95% confidence interval, 0.90–2.13; p = .14).ConclusionsObesity is associated with unique clinical and disease‐related phenotypic features in AML and may influence physician treatment decisions regarding daunorubicin dosing. However, the current study demonstrates that obesity is not a factor in survival, and strict adherence to body surface area‐based dosing is not necessary because dose adjustments do not affect outcomes.
Staff Successes and Challenges with Telecommunications-Facilitated Patient Care in Hybrid Hospital-at-Home during the COVID-19 Pandemic
Zawada, Stephanie , Sweat, Jeffrey, Paulson, Margaret R. , Maniaci, Michael J. , Zawada, Stephanie K , Maniaci, Michael J , Paulson, Margaret R

Healthcare | April 26, 2023 | Volume: 11 | Issue: 9 | Pages: 1223

10.3390/healthcare11091223 | PMID 37174766 Get It

Technology-enhanced hospital-at-home (H@H), commonly referred to as hybrid H@H, became more widely adopted during the COVID-19 pandemic. We conducted focus group interviews with Mayo Clinic staff members (n = 14) delivering hybrid H@H in three separate locations—a rural community health system (Northwest Wisconsin), the nation’s largest city by area (Jacksonville, FL), and a desert metropolitan area (Scottsdale, AZ)—to understand staff experiences with implementing a new care delivery model and using new technology to monitor patients at home during the pandemic. Using a grounded theory lens, transcripts were analyzed to identify themes. Staff reported that hybrid H@H is a complex care coordination and communication initiative, that hybrid H@H faces site-specific challenges modulated by population density and state policies, and that many patients are receiving uniquely high-quality care through hybrid H@H, partly enabled by advances in technology. Participant responses amplify the need for additional qualitative research with hybrid H@H staff to identify areas for improvement in the deployment of new models of care enabled by modern technology.
A Rare Case of Greater Superficial Petrosal Nerve Schwannoma
Wallerius, Katherine P. , Lane, John I. , Sadiq, Qandeel, Carlson, Matthew L.

Otology & Neurotology | April 26, 2023 | Volume: 44 | Issue: 8 | Pages: e610-e611

10.1097/mao.0000000000003889 | PMID 37185234 Get It

U.S. Newspaper Coverage of Lung Cancer Screening From 2010 to 2022
Zippi, Zachary , Cortopassi, Isabel O. , Johnson, Elizabeth , McDermott, Shaunagh , Mergo, Patricia J. , Petranović, Milena , Price, Melissa C. , Stowell, Justin T. , Little, Brent P.

American Journal of Roentgenology | April 25, 2023 | Volume: 221 | Issue: 2 | Pages: 258-271

10.2214/ajr.23.29066 | PMID 36919884 Get It

PC31. Splenius Capitis Muscle Flap for Treatment of Chiari I Malformation Decompression Reconstruction - A Case Series
Movtchan, Nellie V., Lettieri, Salvatore C. , Feiz‐Erfan, Iman

Plastic and Reconstructive Surgery - Global Open | April 25, 2023 | Volume: 11 | Issue: 4S | Pages: 45-45

10.1097/01.gox.0000934484.37436.62 Get It

Contrast-free ultrasound imaging for blood flow assessment of the lower limb in patients with peripheral arterial disease: A feasibility study
Sabeti, Soroosh , Nayak, Rohit , McBane, Robert D. , Fatemi, Mostafa , Alizad, Azra

No container title available | April 25, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2821526/v1 Get It

Abstract While being a relatively prevalent condition particularly among aging patients, peripheral arterial disease (PAD) of lower extremities commonly goes undetected or misdiagnosed due to its symptoms being nonspecific. Additionally, progression of PAD in the absence of timely intervention can lead to dire consequences. Therefore, development of non-invasive and affordable diagnostic approaches can be highly beneficial in detection and treatment planning for PAD patients. In this study, we present a contrast-free ultrasound-based quantitative blood flow imaging technique for PAD diagnosis. The method involves monitoring the variations of blood flow in the calf muscle in response to thigh-pressure-cuff-induced occlusion. Four quantitative metrics are introduced for analysis of these variations. We examine the feasibility of this method through an in vivo study consisting of 14 PAD patients with abnormal ankle-brachial index (ABI) and 8 healthy volunteers. Ultrasound data acquired from 13 legs in the patient group and 13 legs in the healthy group are analyzed. Out of the four utilized metrics, three exhibited significantly different distributions between the two groups (p-value < 0.05). The results of this feasibility study indicate the diagnostic potential of the proposed method for the detection of PAD.
Racial Disparities in Compensation Among US Anesthesiologists: Results of a National Survey of Anesthesiologists
Vandenberg, Megan T., Misra, Lopa , Hertzberg, Linda B., Buckner‐Petty, Skye , Padmanabhan, Asha, Milam, Adam J. , Kraus, Molly, Buckner-Petty, Skye, Milam, Adam J , Kraus, Molly B. , Tollinche, Luis Etienne

Anesthesia & Analgesia | April 25, 2023 | Volume: 137 | Issue: 2 | Pages: 268-276

10.1213/ane.0000000000006484 | PMID 37097908 Get It

BACKGROUND: A racial compensation disparity among physicians across numerous specialties is well documented and persists after adjustment for age, sex, experience, work hours, productivity, academic rank, and practice structure. This study examined national survey data to determine whether there are racial differences in compensation among anesthesiologists in the United States. METHODS: In 2018, 28,812 active members of the American Society of Anesthesiologists were surveyed to examine compensation among members. Compensation was defined as the amount reported as direct compensation on a W-2, 1099, or K-1, plus all voluntary salary reductions (eg, 401[k], health insurance). Covariates potentially associated with compensation were identified (eg, sex and academic rank) and included in regression models. Racial differences in outcome and model variables were assessed via Wilcoxon rank sum tests and Pearson’s χ 2 tests. Covariate adjusted ordinal logistic regression estimated an odds ratio (OR) for the relationship between race and ethnicity and compensation while adjusting for provider and practice characteristics. RESULTS: The final analytical sample consisted of 1952 anesthesiologists (78% non-Hispanic White). The analytic sample represented a higher percentage of White, female, and younger physicians compared to the demographic makeup of anesthesiologists in the United States. When comparing non-Hispanic White anesthesiologists with anesthesiologists from other racial and ethnic minority groups, (ie, American Indian/Alaska Native, Asian, Black, Hispanic, and Native Hawaiian/Pacific Islander), the dependent variable (compensation range) and 6 of the covariates (sex, age, spousal work status, region, practice type, and completed fellowship) had significant differences. In the adjusted model, anesthesiologists from racial and ethnic minority populations had 26% lower odds of being in a higher compensation range compared to White anesthesiologists (OR, 0.74; 95% confidence interval [CI], 0.61–0.91). CONCLUSIONS: Compensation for anesthesiologists showed a significant pay disparity associated with race and ethnicity even after adjusting for provider and practice characteristics. Our study raises concerns that processes, policies, or biases (either implicit or explicit) persist and may impact compensation for anesthesiologists from racial and ethnic minority populations. This disparity in compensation requires actionable solutions and calls for future studies that investigate contributing factors and to validate our findings given the low response rate.